BDBM50382521 CHEMBL2022255

SMILES: COc1ccc(COc2ccc3C(CC(O)=O)COc3c2)cc1-c1c(C)cccc1C

InChI Key: InChIKey=NTLYITJZTYVBSH-UHFFFAOYSA-N

Data: 2 KI  1 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50382521   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Free fatty acid receptor 1 (Homo sapiens (Human))	BDBM50382521 (CHEMBL2022255) Show SMILES COc1ccc(COc2ccc3C(CC(O)=O)COc3c2)cc1-c1c(C)cccc1C |(11.32,-39.26,;11.33,-40.8,;12.67,-41.55,;13.99,-40.78,;15.34,-41.54,;15.34,-43.08,;16.68,-43.85,;18.01,-43.07,;19.35,-43.84,;19.35,-45.38,;20.68,-46.15,;22.02,-45.36,;23.48,-45.83,;23.97,-47.29,;25.48,-47.6,;25.97,-49.06,;26.5,-46.45,;24.38,-44.58,;23.47,-43.34,;22.01,-43.82,;20.67,-43.06,;14.01,-43.86,;12.68,-43.09,;11.36,-43.86,;10.02,-43.09,;10.01,-41.55,;8.69,-43.86,;8.69,-45.41,;10.04,-46.17,;11.36,-45.39,;12.7,-46.15,)| Show InChI InChI=1S/C26H26O5/c1-16-5-4-6-17(2)26(16)22-11-18(7-10-23(22)29-3)14-30-20-8-9-21-19(12-25(27)28)15-31-24(21)13-20/h4-11,13,19H,12,14-15H2,1-3H3,(H,27,28)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	130	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Company Limited Curated by ChEMBL					Assay Description Displacement of 3-[4-({2',6'-dimethyl-6-[(4-[3H])-phenylmethoxy]biphenyl-3-yl}methoxy)phenyl] propanoic acid from human GPR40 receptor expressed in C...				J Med Chem 55: 1538-52 (2012) Article DOI: 10.1021/jm2012968 BindingDB Entry DOI: 10.7270/Q2HQ40X4
					More data for this Ligand-Target Pair
Free fatty acid receptor 1 (Rattus norvegicus)	BDBM50382521 (CHEMBL2022255) Show SMILES COc1ccc(COc2ccc3C(CC(O)=O)COc3c2)cc1-c1c(C)cccc1C |(11.32,-39.26,;11.33,-40.8,;12.67,-41.55,;13.99,-40.78,;15.34,-41.54,;15.34,-43.08,;16.68,-43.85,;18.01,-43.07,;19.35,-43.84,;19.35,-45.38,;20.68,-46.15,;22.02,-45.36,;23.48,-45.83,;23.97,-47.29,;25.48,-47.6,;25.97,-49.06,;26.5,-46.45,;24.38,-44.58,;23.47,-43.34,;22.01,-43.82,;20.67,-43.06,;14.01,-43.86,;12.68,-43.09,;11.36,-43.86,;10.02,-43.09,;10.01,-41.55,;8.69,-43.86,;8.69,-45.41,;10.04,-46.17,;11.36,-45.39,;12.7,-46.15,)| Show InChI InChI=1S/C26H26O5/c1-16-5-4-6-17(2)26(16)22-11-18(7-10-23(22)29-3)14-30-20-8-9-21-19(12-25(27)28)15-31-24(21)13-20/h4-11,13,19H,12,14-15H2,1-3H3,(H,27,28)	KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.60E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Company Limited Curated by ChEMBL					Assay Description Displacement of 3-[4-({2',6'-dimethyl-6-[(4-[3H])-phenylmethoxy]biphenyl-3-yl}methoxy)phenyl] propanoic acid from rat GPR40 receptor expressed in CHO...				J Med Chem 55: 1538-52 (2012) Article DOI: 10.1021/jm2012968 BindingDB Entry DOI: 10.7270/Q2HQ40X4
					More data for this Ligand-Target Pair
Free fatty acid receptor 1 (Homo sapiens (Human))	BDBM50382521 (CHEMBL2022255) Show SMILES COc1ccc(COc2ccc3C(CC(O)=O)COc3c2)cc1-c1c(C)cccc1C |(11.32,-39.26,;11.33,-40.8,;12.67,-41.55,;13.99,-40.78,;15.34,-41.54,;15.34,-43.08,;16.68,-43.85,;18.01,-43.07,;19.35,-43.84,;19.35,-45.38,;20.68,-46.15,;22.02,-45.36,;23.48,-45.83,;23.97,-47.29,;25.48,-47.6,;25.97,-49.06,;26.5,-46.45,;24.38,-44.58,;23.47,-43.34,;22.01,-43.82,;20.67,-43.06,;14.01,-43.86,;12.68,-43.09,;11.36,-43.86,;10.02,-43.09,;10.01,-41.55,;8.69,-43.86,;8.69,-45.41,;10.04,-46.17,;11.36,-45.39,;12.7,-46.15,)| Show InChI InChI=1S/C26H26O5/c1-16-5-4-6-17(2)26(16)22-11-18(7-10-23(22)29-3)14-30-20-8-9-21-19(12-25(27)28)15-31-24(21)13-20/h4-11,13,19H,12,14-15H2,1-3H3,(H,27,28)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	24	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Company Limited Curated by ChEMBL					Assay Description Agonist activity at human GR40 receptor expressed in CHO cells assessed as increase in intracellular calcium concentration after 90 secs by FLIPR ass...				J Med Chem 55: 1538-52 (2012) Article DOI: 10.1021/jm2012968 BindingDB Entry DOI: 10.7270/Q2HQ40X4
					More data for this Ligand-Target Pair